Spero Therapeutics, Inc. (SPRO) Social Stream
SPERO THERAPEUTICS INC (SPRO) Price Targets From Analysts
Use the tables below to see what analysts covering SPERO THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 5 | $47 | $25 | $34.75 | $1.34 | 2493.28% |
| 2022-02-28 | 4 | $40 | $25 | $30.666 | $1.34 | 2188.51% |
| 2022-03-21 | 3 | $43 | $25 | $31.666 | $1.34 | 2263.13% |
| 2022-04-04 | 4 | $43 | $25 | $31.666 | $1.34 | 2263.13% |
| 2022-04-18 | 5 | $37 | $25 | $29.666 | $1.34 | 2113.88% |
| 2022-05-03 | 5 | $37 | $2 | $22 | $1.34 | 1541.79% |
| 2022-05-17 | 5 | $37 | $2 | $14.666 | $1.34 | 994.48% |
| 2022-05-23 | 6 | $10 | $2 | $5.666 | $1.34 | 322.84% |
| 2022-08-11 | 5 | $10 | $2 | $5.666 | $1.34 | 322.84% |
| 2022-09-07 | 5 | $7 | $2 | $4.666 | $1.34 | 248.21% |
| 2022-09-23 | 5 | $8 | $5 | $6.666 | $1.34 | 397.46% |
| 2023-01-26 | 4 | $8 | $5 | $6.333 | $1.34 | 372.61% |
| 2023-04-10 | 5 | $8 | $5 | $6.333 | $1.34 | 372.61% |
| 2023-08-11 | 4 | $8 | $5 | $6.333 | $1.34 | 372.61% |
| 2023-08-14 | 4 | $8 | $5 | $6.666 | $1.34 | 397.46% |
The Trend in the Analyst Price Target
SPRO's average price target has moved down $26.21 over the prior 30 months.
SPRO reports an average of 297.72% for its upside potential over the past 46 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-09-26 | 5 | 8 | 5 | 6.333 | 2.09 | 203.01% |
| 2023-01-26 | 4 | 8 | 5 | 6.333 | 1.85 | 242.32% |
| 2023-01-26 | 5 | 8 | 5 | 6.333 | 1.85 | 242.32% |
| 2023-08-01 | 4 | 8 | 5 | 6.333 | 1.52 | 316.64% |
| 2023-08-14 | 4 | 8 | 5 | 6.666 | 1.37 | 386.57% |
SPRO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 3 | 0 | 1 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 15 months, SPRO's average broker recommendation rating improved by 0.7.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SPRO as an investment opportunity.
- In terms of how SPERO THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1719.79% of that group.
- SPRO has a greater number of analysts covering the stock than 342.41% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, SPERO THERAPEUTICS INC's average analyst price target is greater than 834.61% of them.
- In terms of how SPERO THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -827.73% of that group.
Stocks similar to SPERO THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RYTM, NCNA, and KALA.
View All Top Stocks by Price Target
What is the outlook for SPRO? Use POWR Ratings for clearer insight into price direction.